Search for Clinical Trial Results
Intrahepatic Cholangiocarcinoma - 31 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma Condition:
|
Recruiting |
Study Name: Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) Condition:
|
Recruiting |
Study Name: Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-08-07 Interventions:
|
Withdrawn |
Study Name: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery Condition:
|
Active, not recruiting |
Study Name: Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-04-23 Interventions: Drug: Dasatinib Other Name: SPRYCEL ™ |